Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (Africa)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (Africa)
Karan Gokani’s sweet treats for Diwali – recipes
20/10/2025
‘Stark displays of sexism’ driving women out of architecture, report finds
20/10/2025
Sanae Takaichi on track to become Japan’s first female prime minister after reportedly agreeing to new coalition
20/10/2025
‘Everyone seems to be on Zimmers’ : after 70 years of hip-shaking thrills, is rock’n’roll dead ?
20/10/2025
Don’t cut London’s affordable housing quotas, Labour MPs urge ministers and mayor
20/10/2025
‘You can learn a lot by losing’ : meet Don Manuel, the 104-year-old chess player
20/10/2025